Protagonist Therapeutics set to join S&P SmallCap 600

Protagonist Therapeutics ( NASDAQ: PTGX ) will replace Encore Wire ( NASDAQ: WIRE ) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA ( OTCPK:PRYMY ) is acquiring Encore Wire in a deal expected to be completed soon, pending final conditions. Source: Press Release More on Prysmian S.

p.A., Protagonist, etc.

S&P Global, Inc.: Strong Network Effects And Sticky Products In The Non-Ratings Segment S&P Global: Strong Business Characteristics Make Them A Buy At This Price S&P Global Inc. (SPGI) Stifel 2024 Cross Sector Insight Conference (Transcript) S&P Global names Martina Cheung as president and CEO S&P 500 resumes ticking after data issues caused delay in pricing (update).